Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.
about
Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine groupMechanism of differential activities of ofloxacin enantiomersAntibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases.Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potentialContribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone.Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.CP-115,953 stimulates cytokine production by lymphocytes.Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.Toxicity of quinolone antimicrobial agents.Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.Population Pharmacokinetics and Penetration into Prostatic, Seminal, and Vaginal Fluid for Ciprofloxacin, Levofloxacin, and Their Combination
P2860
Q24671373-87C24213-3A87-4E3B-B0B6-FFDE84210ED4Q24675769-A56585CE-EDFD-4E9E-897F-27D3D10F7445Q33696363-73DEEA22-A097-4B99-9414-56A8B5ED593EQ35810950-EFF5534A-02BD-42A8-B848-2EC2EB632538Q35897465-FEA48357-F6C4-4EAD-8BEA-F6CCE78112EEQ35904133-C47A8628-092B-481C-9C8E-3F4BF59A3CE8Q36757682-424DFDE9-AD5B-48D0-B04F-2CAE894E445BQ39479356-74F2DDCB-3B88-41A3-9BAF-61D42193724BQ39490260-98F33A8B-536D-4328-9859-BC19FF048288Q39559188-524ED692-3BDC-4289-8F23-602CF1372FA9Q39779184-B831887B-64A7-495C-AA98-BEA0FED7F34DQ39867252-59037029-0F65-420B-B50D-4E11001E31BAQ40526656-04949864-290A-4960-82C2-66D58147CCCEQ54654852-168BC030-27BF-47EF-9318-2945AF12E63AQ57240424-173D755B-85BC-42E3-A451-56B59DD0E425
P2860
Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Significance of the methyl gro ...... malian type II topoisomerases.
@en
type
label
Significance of the methyl gro ...... malian type II topoisomerases.
@en
prefLabel
Significance of the methyl gro ...... malian type II topoisomerases.
@en
P2093
P2860
P356
P1476
Significance of the methyl gro ...... malian type II topoisomerases.
@en
P2093
Hayakawa I
P2860
P304
P356
10.1128/AAC.35.2.309
P407
P577
1991-02-01T00:00:00Z